In glioma and GBM cell lines, inflammatory markers like cyclooxygenase-2 (COX-2), cytosolic phospholipase, interleukin-1β (IL-1β), and APP have been found to be overexpressed, suggesting a possible link between inflammation and disease progression [117]. This evidence concerns the gene PTGS2 and glioblastoma.